14 The authors declare no potential conflicts of interest 2 15 ABSTRACT 16 The cohesin complex plays a major role in folding the human genome into 3D 17 structural domains. Mutations in members of the cohesin complex are known early 18 drivers of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), 19 with STAG2 the most frequently mutated complex member. Here we use functional 20 genomics to investigate the impact of chronic STAG2 loss on three-dimensional 21 genome structure and transcriptional programming in a clinically relevant model of 22 chronic STAG2 loss. The chronic loss of STAG2 led to loss of smaller loop domains 23 and the maintenance/formation of large domains which in turn led to altered genome 24 compartmentalisation. These changes in genome structure were linked with altered 25 gene expression, including deregulation of the HOXA locus and the MAPK signalling 26 pathway, which may contribute to disease development and response to therapy.
9 180 of smaller loops (<100 kb) in the STAG2 cells. Although significantly fewer loops 181 were called in the STAG2 cells, this is not caused by the significant loss of loops of 182 any specific size. Importantly, although much weaker loop peak signals were 183 present in the STAG2 cells, the formation of new loops was not seen. Aggregate 184 Peak Analysis (APA) of the consensus loop lists showed that despite the low loop 185 peak signal within the STAG2 cells, clear peak foci were visible, albeit with a 186 reduced pixel signal intensity, when compared to STAG2-WT cells ( Figure 2F ). 199 Eigenvector scoring of the STAG2 HiChIP data showed that ~10% of 200 compartments scored as type B in the WT cells had switched to type A 201 compartments, whilst ~8% of compartments scored as A were type B compartments 11 225 maturation", "cell death" and "cell morphology" (Figure S4 ). This suggests that 226 whilst the majority of genes and pathways have not become highly deregulated, the 227 chronic loss of STAG2 function has resulted in the transcriptional deregulation of key 228 leukaemogenic pathways, which may contribute to disease development/phenotype.
229
The disruption in transcription in STAG2 was unexpected, as previously published 230 data had suggested that STAG1 was predominantly responsible for cohesin binding 231 near gene promoter regions and thereby regulating transcription, whilst STAG2 may 232 be more involved in the maintenance of global 3D chromatin structure [18] . To 233 assess this, the ChIP-Seq data was used to re-analyse STAG1 and STAG2 binding 234 surrounding transcription start sites (TSSs). Average signal density plots confirmed 235 that, on a genome wide level in the STAG2-WT cells, STAG1 was predominantly 236 bound at TSSs in comparison to STAG2 ( Figure 4C) . Intriguingly, STAG1 binding at 237 TSSs was nearly identical in the STAG2 cells when compared to the STAG2-WT, 238 suggesting that STAG1 based cohesin complexes contribute to the vast majority of 239 transcription associated interactions in the genome.
240 Intriguingly, in wild type cells, STAG2 was predominantly bound near the TSSs or 241 promoter regions of the 691 differentially expressed genes than STAG1 ( Figure 4C ).
242 Moreover, STAG1 binding at the TSS did not change in the setting of chronic STAG2
243 loss, indicating that at these sites, STAG1 was unable to compensate for STAG2.
244 The presence of STAG2, and the lack of STAG1 compensation, at/near the TSSs of 245 these genes further suggest that STAG2 may play a role in linking transcription 246 regulation regions with promoters and enhancers and/or protecting certain promoters 247 from interactions with enhancers in 3-dimensional space.
248 GENE EXPRESSION CHANGES MEDIATED BY LOSS OF STAG2 ARE LINKED

WITH ALTERED DOMAIN STRUCTURE
250 To further examine the relationship between STAG2 mediated changes in genome 251 structure and altered transcription, we specifically focused on the HOXA cluster, as 252 multiple HOXA genes were deregulated upon chronic STAG2 loss, and deregulation 253 of these genes is highly associated with leukaemogenesis [19] . Interestingly, the 254 region containing the HOXA cluster features extensive structural control, with many 255 CTCF/cohesin sites positioned throughout the locus.
256 From the ChIP-Seq data, seven strong CTCF sites were identified that were 257 associated with the HOXA locus ( Figure 5A ). These sites linked the 3' region of a 258 TAD (300 kb), to an upstream anchor within the SKAP2 gene. The major boundary 259 edge of this TAD (termed C7/9 boundary (C=CTCF)) was located between the 307 One gene of interest was DUSP4, which has been linked with sensitivity to MEK 308 inhibition [21] . Analysis of DUSP4 expression in the same publically available 309 datasets described earlier showed that DUSP4 expression was lower, but not 310 significantly, in STAG2 mutant samples compared to STAG2 wild-type samples 311 ( Figure S8 ). This was likely due to the limited number of STAG2 mutated samples, 312 the reduced blast cell fraction in these samples and the more subtle changes in 313 expression of these genes observed in our ∆STAG2 model. 403
In our study we observed deregulation of the expression of early HOXA genes;
404 aberrant HOXA gene expression is a feature of different sub-types of AML [19, 27] .
405 In the STAG2-WT cells, the HOXA1-7 genes were expressed at very low levels and 521 RNA-SEQ data processing 522 FASTQ files were downloaded from BaseSpace sequencing hub and checked for 523 quality using FASTQC. Reads were aligned to hg19 using STAR and Ensemble 524 gene annotation. Gene count data generated by STAR was used as input to 525 DESeq2 to generate differential expression data as well as normalised count tables.
526 ChIP-SEQ data processing 527 FASTQ files were downloaded from BaseSpace sequencing hub and checked for 528 quality using FASTQC. Reads were aligned to hg19 using Bowtie2 using the "very- 
